{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:13:17Z","timestamp":1758845597476,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaci.2022.11.013","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:30:51Z","timestamp":1669930251000},"page":"922-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders"],"prefix":"10.1016","volume":"151","author":[{"given":"Kai M.T.","family":"Sauerwein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph B.","family":"Geier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman F.","family":"Stemberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Rossmanith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Akyaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Illes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M.","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.11.013_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fimmu.2022.827048","article-title":"Antigen-specific CD4+ T-cell activation in primary antibody deficiency after BNT162b2 mRNA COVID-19 vaccination","volume":"13","author":"Sauerwein","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.013_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.anai.2022.06.009","article-title":"Immunizing the imperfect immune system: coronavirus disease 2019 vaccination in patients with inborn errors of immunity","volume":"129","author":"Durkee-Shock","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.11.013_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.912571","article-title":"Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study","volume":"13","author":"Shields","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.013_bib4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/cells11121918","article-title":"T-cell defects associated to lack of spike-specific antibodies after BNT162b2 full immunization followed by a booster dose in patients with common variable immune deficiencies","volume":"11","author":"Pulvirenti","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2022.11.013_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907125","article-title":"Specific antibody and the T-cell response elicited by BNT162b2 boosting after two ChAdOx1 nCoV-19 in common variable immunodeficiency","volume":"13","author":"Goda","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.11.013_bib6","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaip.2022.02.030","article-title":"Immunogenicity of a third COVID-19 messenger RNA vaccine dose in primary immunodeficiency disorder patients with functional B-cell defects","volume":"10","author":"Gernez","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.11.013_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-021-04060-7","article-title":"Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination","volume":"600","author":"Cho","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.11.013_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/v14030532","article-title":"Evolution of anti-RBD IgG avidity following SARS-CoV-2 infection","volume":"14","author":"Tauzin","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jaci.2022.11.013_bib10","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.4049\/jimmunol.165.8.4725","article-title":"Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency","volume":"165","author":"Bonhomme","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.11.013_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ijpara.2020.08.003","article-title":"Potential functions of atypical memory B cells in Plasmodium-exposed individuals","volume":"50","author":"Braddom","year":"2020","journal-title":"Int J Parasitol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922016189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922016189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:40:25Z","timestamp":1758793225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922016189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0091674922016189"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.013","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}